These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 8843099

  • 1. Leukaemia inhibitory factor treatment stimulates muscle regeneration in the mdx mouse.
    Kurek J, Bower J, Romanella M, Austin L.
    Neurosci Lett; 1996 Jul 19; 212(3):167-70. PubMed ID: 8843099
    [Abstract] [Full Text] [Related]

  • 2. Leukemia inhibitory factor ameliorates muscle fiber degeneration in the mdx mouse.
    Austin L, Bower JJ, Bennett TM, Lynch GS, Kapsa R, White JD, Barnard W, Gregorevic P, Byrne E.
    Muscle Nerve; 2000 Nov 19; 23(11):1700-5. PubMed ID: 11054748
    [Abstract] [Full Text] [Related]

  • 3. Leukemia inhibitory factor (LIF) infusion stimulates skeletal muscle regeneration after injury: injured muscle expresses lif mRNA.
    Barnard W, Bower J, Brown MA, Murphy M, Austin L.
    J Neurol Sci; 1994 May 19; 123(1-2):108-13. PubMed ID: 8064301
    [Abstract] [Full Text] [Related]

  • 4. AM424: history of a novel drug candidate.
    Kurek J.
    Clin Exp Pharmacol Physiol; 2000 Jul 19; 27(7):553-7. PubMed ID: 10874517
    [Abstract] [Full Text] [Related]

  • 5. Leukaemia inhibitory factor increases myoblast replication and survival and affects extracellular matrix production: combined in vivo and in vitro studies in post-natal skeletal muscle.
    White JD, Davies M, Grounds MD.
    Cell Tissue Res; 2001 Oct 19; 306(1):129-41. PubMed ID: 11683174
    [Abstract] [Full Text] [Related]

  • 6. Functional properties of regenerating skeletal muscle following LIF administration.
    Gregorevic P, Hayes A, Lynch GS, Williams DA.
    Muscle Nerve; 2000 Oct 19; 23(10):1586-8. PubMed ID: 11003796
    [Abstract] [Full Text] [Related]

  • 7. Leukemia inhibitory factor enhances regeneration in skeletal muscles after myoblast transplantation.
    White JD, Bower JJ, Kurek JB, Austin L.
    Muscle Nerve; 2001 May 19; 24(5):695-7. PubMed ID: 11317281
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro myoblast to myotube transformations in the presence of leukemia inhibitory factor.
    Vakakis N, Bower J, Austin L.
    Neurochem Int; 1995 May 19; 27(4-5):329-35. PubMed ID: 8845733
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. LIF (AM424), a promising growth factor for the treatment of ALS.
    Kurek JB, Radford AJ, Crump DE, Bower JJ, Feeney SJ, Austin L, Byrne E.
    J Neurol Sci; 1998 Oct 19; 160 Suppl 1():S106-13. PubMed ID: 9851659
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Postnatal profiles of myogenic regulatory factors and the receptors of TGF-beta 2, LIF and IGF-I in the gastrocnemius and rectus femoris muscles of dy mouse.
    Sakuma K, Watanabe K, Sano M, Uramoto I, Totsuka T.
    Acta Neuropathol; 2000 Feb 19; 99(2):169-76. PubMed ID: 10672324
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Extracellular matrix, growth factors, genetics: their influence on cell proliferation and myotube formation in primary cultures of adult mouse skeletal muscle.
    Maley MA, Davies MJ, Grounds MD.
    Exp Cell Res; 1995 Jul 19; 219(1):169-79. PubMed ID: 7628533
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.